- Home
- EYPT vs OPY Comparison
EYPT vs OPY Comparison
Compare EYPT & OPY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYPT
- OPY
- Stock Information
- Founded
- EYPT 1987
- OPY 1881
- Country
- EYPT United States
- OPY United States
- Employees
- EYPT N/A
- OPY N/A
- Industry
- EYPT Biotechnology: Laboratory Analytical Instruments
- OPY Investment Bankers/Brokers/Service
- Sector
- EYPT Industrials
- OPY Finance
- Exchange
- EYPT Nasdaq
- OPY Nasdaq
- Market Cap
- EYPT 741.0M
- OPY 766.7M
- IPO Year
- EYPT 2005
- OPY N/A
- Fundamental
- Price
- EYPT $11.09
- OPY $70.45
- Analyst Decision
- EYPT Strong Buy
- OPY
- Analyst Count
- EYPT 7
- OPY 0
- Target Price
- EYPT $24.29
- OPY N/A
- AVG Volume (30 Days)
- EYPT 643.4K
- OPY 53.7K
- Earning Date
- EYPT 08-06-2025
- OPY 08-01-2025
- Dividend Yield
- EYPT N/A
- OPY 1.02%
- EPS Growth
- EYPT N/A
- OPY 41.03
- EPS
- EYPT N/A
- OPY 7.71
- Revenue
- EYPT $51,898,000.00
- OPY $1,400,370,000.00
- Revenue This Year
- EYPT N/A
- OPY N/A
- Revenue Next Year
- EYPT N/A
- OPY N/A
- P/E Ratio
- EYPT N/A
- OPY $9.15
- Revenue Growth
- EYPT 2.99
- OPY 14.40
- 52 Week Low
- EYPT $3.91
- OPY $47.39
- 52 Week High
- EYPT $13.99
- OPY $77.83
- Technical
- Relative Strength Index (RSI)
- EYPT 61.85
- OPY 46.55
- Support Level
- EYPT $10.22
- OPY $70.93
- Resistance Level
- EYPT $11.28
- OPY $74.23
- Average True Range (ATR)
- EYPT 0.71
- OPY 2.00
- MACD
- EYPT 0.04
- OPY -0.58
- Stochastic Oscillator
- EYPT 89.89
- OPY 1.47
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
About OPY Oppenheimer Holdings Inc. (DE)
Oppenheimer Holdings Inc conducts activities in the securities industry. The company is involved in retail securities brokerage, investment banking (both corporate and public finance), institutional sales and trading, market-making, research, trust services, and investment advisory and asset management services. The company has two segments: Wealth Management, and Capital Markets. IT generates maximum revenue from Wealth Management Segment which includes commissions and fee income earned on assets under management (AUM), net interest earnings on client margin loans and cash balances, fees from money market funds, custodian fees and other activities. The company generates the majority of its revenue from the Americas, with the rest from Europe, the Middle East, and Asia.